drug · antibody
patient view →retifanlimab
Marketedupdated 2mo agoby $INCY INCYTE CORP🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 16 investigational indications.
targets
Programmed cell death protein 1
all catalysts(6)
approval · 5
phase 3 initiation · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that